logo
Plus   Neg
Share
Email

Lonza Maintains 2019 Outlook

Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, said that it maintained its 2019 outlook based on the strong performance of its core healthcare businesses in Pharma Biotech & Nutrition, and taking into account the continued headwinds in its Specialty Ingredients portfolio.

For 2019, the company confirmed that mid-to-high-single digit sales growth, sustained high CORE EBITDA margin level.

Lonza adjusted its mid-term Guidance, following the disposal of its former Water Care business unit in February 2019, and to emphasize its strategic focus on growth in its core healthcare businesses.

The adjusted Mid-Term Guidance for Lonza's continuing operations, excluding the Water Care business unit, is confirmed. It still expects sales of 7.1 billion Swiss francs, CORE EBITDA margin of 30.5%.

Lonza said that the newly aligned segment Lonza Pharma Biotech & Nutrition performed strongly compared with the first-quarter of prior year and ahead of expectations. Lonza's newly aligned Specialty Ingredients segment faced challenges and the businesses performed below expectations with sales on the same level as in the first-quarter of 2018.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Snap Inc. (SNAP) Tuesday reported a narrower loss for the second quarter that also was better than Wall Street's expectations, as revenues surged on strong user growth. The company issued a strong revenue guidance for the current quarter, sending its shares up 10 percent in after-hours trade. California-based... Shares of Texas Instruments Inc. (TXN) gained over 6% in extended trading session on Tuesday after the analog chip maker reported a second-quarter profit and revenue that trumped analysts' expectations. The company also issued a strong financial outlook for the third quarter. Dallas, Texas-based Texas... Justin Sun, the entrepreneur who founded the cryptocurrency platform TRON, has postponed his charity lunch with billionaire investor Warren Buffett due to ill health. "TRON Foundation announces postponement of Warren Buffett lunch, press conferences after founder Justin Sun falls ill with kidney stones....
Follow RTT